Literature DB >> 5323377

Clinical experience with the antiviral drug marboran (1-methylisatin 3-thiosemicarbazone).

D J Bauer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5323377     DOI: 10.1111/j.1749-6632.1965.tb12545.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  22 in total

Review 1.  Antiviral chemotherapy: the first decade.

Authors:  D J Bauer
Journal:  Br Med J       Date:  1973-08-04

2.  Sensitivity of herpes simplex virus, vaccinia virus, and adenoviruses to deoxyribonucleic acid inhibitors and thiosemicarbazones in a plaque suppression test.

Authors:  E C Herrmann
Journal:  Appl Microbiol       Date:  1968-08

3.  Life-threatening dermatoses.

Authors:  D L Cram
Journal:  Calif Med       Date:  1973-02

4.  Properties of the CV1 strain of vaccinia virus. 3. Sensitivity to thiosemicarbazone.

Authors:  T J John
Journal:  Arch Gesamte Virusforsch       Date:  1969

Review 5.  The effects of therapeutic measures in diseases caused by viruses.

Authors:  R P Larke
Journal:  Can Med Assoc J       Date:  1966-11-05       Impact factor: 8.262

Review 6.  The poxviruses.

Authors:  W K Joklik
Journal:  Bacteriol Rev       Date:  1966-03

7.  Problems of smallpox immunization.

Authors:  A L Libov
Journal:  Indian J Pediatr       Date:  1967-12       Impact factor: 1.967

8.  Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine.

Authors:  Benjamin K Quintel; Archana Thomas; Danae E Poer DeRaad; Mark K Slifka; Ian J Amanna
Journal:  Vaccine       Date:  2018-12-31       Impact factor: 3.641

9.  Effect of methisazone and other drugs on mouse hemophoietic colony formation in vitro.

Authors:  T A McNeill
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

10.  Suppression of immune and hemopoietic cellular responses by methisazone.

Authors:  T A McNeill; W A Fleming; S F McClure; M Killen
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.